Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Synerx Pharma, LLC
ClinicalTrials.gov Identifier:
NCT01467687
First received: October 31, 2011
Last updated: November 8, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)